Get the Stockscreener App
1.11
3.48%
-0.04
Gossamer Bio Inc Stock (GOSS) Latest News
Are Smart Investors Making the Right Decision? Gossamer Bio Inc (GOSS) - SETE News
Gossamer Bio Inc (GOSS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Octagon Capital Advisors LP Increases Stake in Gossamer Bio Inc - GuruFocus.com
Real-Time Update: Gossamer Bio Inc (GOSS) Stock Navigates the Market with Up-to-Date Data - The News Heater
Investor’s Delight: Gossamer Bio Inc (GOSS) Closes Weak at 1.02, Down -0.97 - The Dwinnex
Gossamer Bio (NASDAQ:GOSS) Earns "Buy" Rating from HC Wainwright - MarketBeat
Analysts Offer Predictions for Gossamer Bio FY2029 Earnings - MarketBeat
Gossamer Bio showcases seralutinib studies at PVRI Congress - Investing.com
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
Gossamer Bio’s (GOSS) “Buy” Rating Reiterated at HC Wainwright - Defense World
HC Wainwright Weighs in on Gossamer Bio FY2029 Earnings - Defense World
Vanguard Group Inc Reduces Stake in Gossamer Bio Inc - GuruFocus.com
Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges - Simply Wall St
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress - Business Wire
GOSS News Today | Why did Gossamer Bio stock go up today? - MarketBeat
Cantor Fitzgerald Estimates Gossamer Bio FY2025 Earnings - Defense World
Brokers Set Expectations for Gossamer Bio FY2025 Earnings - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 12.8% in December - MarketBeat
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by Geode Capital Management LLC - Defense World
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance
12 Best Penny Stocks to Invest in According to the Media - Insider Monkey
3 US Penny Stocks With Market Caps Over $100M - Simply Wall St
Gossamer Bio, Inc. (NASDAQ:GOSS) Sees Large Increase in Short Interest - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Up 10.0% in December - Defense World
Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know - MSN
The Manufacturers Life Insurance Company Boosts Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
US Penny Stocks: 3 Picks With Market Caps Under $200M - Simply Wall St
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio - The Manila Times
XOMA Royalty Acquires Pulmokine for $20 Million Adding the - GlobeNewswire
Gossamer Bio: Q3 Earnings Snapshot - Marketscreener.com
Adicet Bio Inc (NASDAQ: ACET) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
GSA Capital Partners LLP Invests $67,000 in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Gossamer Bio Inc (GOSS)Monday, Aug 26, 2024 - Smartkarma
All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy - MSN
US Bancorp DE Makes New $39,000 Investment in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance
Leerink Partnrs Raises Earnings Estimates for Gossamer Bio - Defense World
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance
HC Wainwright Increases Earnings Estimates for Gossamer Bio - MarketBeat
FMR LLC's Strategic Acquisition of Gossamer Bio Inc Shares - GuruFocus.com
Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts - Yahoo Finance
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Gossamer Bio Grants 183K Stock Options to New Hires at $0.88 Per Share | GOSS Stock News - StockTitan
Gossamer Bio (NASDAQ:GOSS) Earns Buy Rating from HC Wainwright - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations - TipRanks
GOSSGossamer Bio, Inc. Latest Stock News & Market Updates - StockTitan
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):